Experience of the COVID-19 Pandemic in the Care of Patients with Predominantly Antibody Deficiencies (PADs)-A Qualitative Study with Perspectives from Both Patients and Nurses.

Ramona Fust, Sofia Nyström, Britt Åkerlind, Åsa Nilsdotter-Augustinsson, Christina Petersson
Author Information
  1. Ramona Fust: Department of Infectious Diseases in Region Östergötland, Linköping University, 583 30 Linköping, Sweden. ORCID
  2. Sofia Nyström: Department of Biomedical and Clinical Sciences, Linköping University, 583 30 Linköping, Sweden. ORCID
  3. Britt Åkerlind: Department of Infection Control and Hygiene, Linköping University Hospital Sweden, 583 30 Linköping, Sweden.
  4. Åsa Nilsdotter-Augustinsson: Department of Infectious Diseases in Region Östergötland, Linköping University, 583 30 Linköping, Sweden. ORCID
  5. Christina Petersson: Jönköping Academy for Improvement of Health and Welfare, Jönköping University, 551 11 Jönköping, Sweden.

Abstract

One of the risk groups during the COVID-19 pandemic was people with predominantly antibody deficiencies (PADs) that have a compromised immune system. In the absence of evidence and clinical experience, there were challenges for patients in their daily life and for staff in counseling during this time. Therefore, the aim of this study was to explore the experiences of PAD patients and nurses during the COVID-19 pandemic. Focus group interviews with patients (n = 12) and nurses (n = 12) were performed separately, which were then analyzed using content analysis. The daily life of PAD patients was affected during the pandemic, with concerns about becoming seriously ill. Social isolation and adherence to recommendations by the majority of the Swedish population resulted in patients feeling infectiously healthier during this period. The rapid transition of specialist care to telemedicine care encounters was an important measure taken to address patients' concerns and questions according to both patients and nurses. In addition, patients expressed a need for a coordinated care plan to facilitate access to integrated care. The high level of trust for authorities in Sweden was related to the high compliance with the recommendations, which reduced the spread of the infection. The role of specialized care is an important support for PAD patients, which was particularly evident during the pandemic. Information transfer to a specific risk group, such as people with PADs, is important and can usefully be coordinated by their specialist clinic. Telemedicine meetings are an important complement for people with PADs and need to be further elaborated. Also, there is a need to clarify how to better coordinate primary and specialized care.

Keywords

References

  1. J Adv Nurs. 2008 Apr;62(1):107-15 [PMID: 18352969]
  2. Lancet. 1991 Jul 20;338(8760):162-6 [PMID: 1712881]
  3. PLoS One. 2024 Feb 26;19(2):e0298461 [PMID: 38408111]
  4. AIDS Patient Care STDS. 2023 Oct;37(10):459-468 [PMID: 37862076]
  5. J Allergy Clin Immunol Pract. 2020 Jul - Aug;8(7):2135-2141 [PMID: 32426217]
  6. Acta Paediatr. 2020 Dec;109(12):2459-2471 [PMID: 32951258]
  7. Psychiatry Res. 2020 Jul;289:113098 [PMID: 32434092]
  8. Front Immunol. 2018 Jul 02;9:1308 [PMID: 30034388]
  9. Health Econ Policy Law. 2022 Jan;17(1):48-61 [PMID: 34372959]
  10. Clin Exp Immunol. 2015 Feb;179(2):146-60 [PMID: 25384609]
  11. J Clin Immunol. 2016 Jul;36(5):450-61 [PMID: 27091140]
  12. J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1929-1957.e5 [PMID: 30797077]
  13. J Clin Immunol. 2022 Oct;42(7):1473-1507 [PMID: 35748970]
  14. J Clin Immunol. 2017 Oct;37(7):615-616 [PMID: 28819871]
  15. J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):38-59 [PMID: 26563668]
  16. Patient Educ Couns. 2023 Sep;114:107788 [PMID: 37173221]
  17. J Clin Immunol. 2022 Feb;42(2):240-252 [PMID: 34787773]
  18. APMIS. 2021 Jul;129(7):320-323 [PMID: 33622025]
  19. Front Immunol. 2018 Aug 08;9:1837 [PMID: 30147696]
  20. Cureus. 2020 Sep 14;12(9):e10453 [PMID: 33072461]
  21. World Med Health Policy. 2022 Sep;14(3):507-527 [PMID: 34226854]
  22. Ann Epidemiol. 2021 Feb;54:21-26 [PMID: 33242596]
  23. Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211044344 [PMID: 34565194]
  24. Clin Immunol. 2022 Mar;236:108931 [PMID: 35063670]
  25. Lakartidningen. 2020 Nov 23;117: [PMID: 33230806]
  26. J Infect. 2023 Apr;86(4):415-416 [PMID: 36682628]
  27. Clin Exp Pediatr. 2021 Oct;64(10):519-520 [PMID: 33957033]
  28. J Allergy Clin Immunol. 2020 Aug;146(2):417-428 [PMID: 32057767]
  29. Int J Qual Health Care. 2007 Dec;19(6):349-57 [PMID: 17872937]
  30. Scand J Prim Health Care. 2015 Jun;33(2):100-6 [PMID: 25961964]
  31. Z Gesundh Wiss. 2022;30(12):2753-2760 [PMID: 33936932]
  32. J Am Acad Orthop Surg. 2020 Jun 1;28(11):e469-e476 [PMID: 32301818]

Word Cloud

Created with Highcharts 10.0.0patientscarepandemicPADsimportantCOVID-19peoplelifePADnursesneedriskdailygroupn=12concernsrecommendationsspecialisttelemedicinecoordinatedhighspecializedPatientsOnegroupspredominantlyantibodydeficienciescompromisedimmunesystemabsenceevidenceclinicalexperiencechallengesstaffcounselingtimeThereforeaimstudyexploreexperiencesFocusinterviewsperformedseparatelyanalyzedusingcontentanalysisaffectedbecomingseriouslyillSocialisolationadherencemajoritySwedishpopulationresultedfeelinginfectiouslyhealthierperiodrapidtransitionencountersmeasuretakenaddresspatients'questionsaccordingadditionexpressedplanfacilitateaccessintegratedleveltrustauthoritiesSwedenrelatedcompliancereducedspreadinfectionrolesupportparticularlyevidentInformationtransferspecificcanusefullyclinicTelemedicinemeetingscomplementelaboratedAlsoclarifybettercoordinateprimaryExperiencePandemicCarePredominantlyAntibodyDeficiencies-AQualitativeStudyPerspectivesNurseschronicconditionscoordinationeverydaynursing

Similar Articles

Cited By